Effect of Y-27632 on release of cytokines from peripheral T cells in asthmatic patients and normal subjects. 2004

Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
First Department of Internal Medicine, Faculty of Medicine, School of Medicine, Gunma University, 3-39-15, Showa-machi, Maebashi, Gunma 371-8511, Japan. aiharam@showa.gunma-u.ac.jp

Previously we have reported that Y-27632, a selective inhibitor of Rho-associated protein kinases (ROCKs) for RhoA, suppressed concanavalin A (Con A)-induced secretion of cytokines from peripheral T cells of normal persons. Recent studies suggested its usefulness for clinical management of bronchial asthma. We examined effect of Y-27632 on release of cytokines from T cells of asthmatic patients. Peripheral T cells of six asthmatic subjects and six normal persons were stimulated with Con A for 24 h in the presence of Y-27632. The concentrations of IL-2, interferon (IFN)-gamma, IL-4, and IL-5 in supernatant were measured. Y-27632 down-regulated secretion of IL-2 and IFN-gamma and weakly decreased secretion of IL-4 and IL-5 from Con A-activated T cells in the asthmatics. The reduced secretion of IFN-gamma and IL-4 in the asthmatics was inferior to that in the normal subjects. Our data suggested that the involvement of RhoA/ROCK pathway in TCR-mediated secretion of IFN-gamma and IL-4 in patients with bronchial asthma differed from that in healthy persons.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008297 Male Males
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
March 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
June 1998, Clinical and experimental immunology,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
May 1996, Biochemical Society transactions,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
February 2001, Journal of immunology (Baltimore, Md. : 1950),
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
March 1990, The American review of respiratory disease,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
May 1980, Annals of allergy,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
February 2002, The European respiratory journal,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
December 2018, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
November 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Masayuki Aihara, and Kunio Dobashi, and Kunihiko Iizuka, and Tsugio Nakazawa, and Masatomo Mori
January 1999, International archives of allergy and immunology,
Copied contents to your clipboard!